Phase I Clinical Trial of Recombinant Newcastle Disease Virus for Canine Intracranial Meningiomas

Study Progress Update

Our study into the use of Newcastle Disease Virus for the treatment of canine meningiomas is now closed. Thank you to all those who participated.


If you have questions about your participation in the study or about the study results, please contact:

Ms. Mindy Quigley, Clinical Trials Coordinator
Office Phone: 540-231-1363 | Email: